Chemotherapy of Systemic Mycoses

John E. Bennett

Research output: Contribution to journalReview articlepeer-review

Abstract

PROGRESS in chemotherapy of systemic mycoses has been sufficiently slow to recall the lament of Ecclesiastes: “The thing that hath been, it is that which shall be; and that which is done is that which shall be done; and there is no new thing under the sun.” Comparison of this review with another published in the Journal in 19631 may reinforce such a conviction. Still, something remains to be said for broadening our knowledge of old drugs and gleaning what one can about newer agents. Polyene Antibiotics This large group of antibiotics includes three drugs commercially available in this country:.

Original languageEnglish (US)
Pages (from-to)30-32
Number of pages3
JournalNew England Journal of Medicine
Volume290
Issue number1
DOIs
StatePublished - Jan 3 1974

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Chemotherapy of Systemic Mycoses'. Together they form a unique fingerprint.

Cite this